UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

The Lancet (British edition), 2012-01, Vol.379 (9813), p.322-334

2012

Link zum Volltext

Verfügbarkeit prüfen

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.615-621

2012

Link zum Volltext

Verfügbarkeit prüfen

A comparative analysis of different automated von Willebrand factor glycoprotein Ib‐binding activity assays in well typed von Willebrand disease patients

Journal of thrombosis and haemostasis, 2018-07, Vol.16 (7), p.1268-1277

2018

Link zum Volltext

Verfügbarkeit prüfen

Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium

Leukemia research, 2016-07, Vol.46, p.26-29

2016

Link zum Volltext

Verfügbarkeit prüfen

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole

European journal of clinical microbiology & infectious diseases, 2012-06, Vol.31 (6), p.1173-1179

2012

Link zum Volltext

Verfügbarkeit prüfen

Patient self‐management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life

Journal of thrombosis and haemostasis, 2004-04, Vol.2 (4), p.584-591

2004

Link zum Volltext

Verfügbarkeit prüfen

B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS

HemaSphere, 2023-05, Vol.7 (S2), p.5-5

2023

Link zum Volltext

Verfügbarkeit prüfen

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL

HemaSphere, 2022-06, Vol.6, p.266-267

2022

Link zum Volltext

Verfügbarkeit prüfen

Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions

Experimental hematology & oncology, 2017-04, Vol.6 (1), p.9-4, Article 9

2017

Link zum Volltext

Verfügbarkeit prüfen

Principles of care for the diagnosis and treatment of von Willebrand disease

Haematologica (Roma), 2013-05, Vol.98 (5), p.667-674

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon

Thrombosis and haemostasis, 2003-08, Vol.90 (2), p.260

2003

Link zum Volltext

Verfügbarkeit prüfen

Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: a randomized double‐blind clinical trial

Journal of thrombosis and haemostasis, 2003-04, Vol.1 (4), p.714-717

2003

Link zum Volltext

Verfügbarkeit prüfen

SENSITIZATION TO THE MAMMALIAN OLIGOSACCHARIDE GALACTOSE-ALPHA-1,3- GALACTOSE (ALPHA-GAL): EXPERIENCE IN A FLEMISH CASE SERIES

Acta clinica belgica (English ed. Online), 2013-05, Vol.68 (3), p.206-209

2013

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with Wilms' Tumor Antigen ( WT1) mRNA-Electroporated Dendritic Cells as an Adjuvant Treatment in 60 Cancer Patients: Report of Clinical Effects and Increased Survival in Acute Myeloid Leukemia, Metastatic Breast Cancer, Glioblastoma and Mesothelioma

Cytotherapy (Oxford, England), 2016-06, Vol.18 (6), p.S13-S14

2016

Link zum Volltext

Verfügbarkeit prüfen

Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity

Journal of thrombosis and haemostasis, 2012-09, Vol.10 (9), p.1938-1943

2012

Link zum Volltext

Verfügbarkeit prüfen

The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth

Clinical transplantation, 2012-01, Vol.26 (1), p.E62-E70

2012

Link zum Volltext

Verfügbarkeit prüfen

The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study

Journal of thrombosis and haemostasis, 2007-05, Vol.5 (5), p.931-936

2007

Link zum Volltext

Verfügbarkeit prüfen

A warning about agranulocytosis with the use of cocaine adulterated with levamisole

Acta clinica belgica (English ed. Online), 2011-05, Vol.66 (3), p.226-227

2011

Link zum Volltext

Verfügbarkeit prüfen

Medical and surgical management of paraneoplastic pyoderma gangrenosum--a case report and review of the literature

Acta clinica belgica (English ed. Online), 2010-01, Vol.65 (1), p.37-40

2010

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic quality control of oral anticoagulant therapy comparing the short‐acting acenocoumarol and the long‐acting phenprocoumon

British journal of haematology, 2002-06, Vol.117 (4), p.940-946

2002

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial

Archives of internal medicine (1960), 2003-11, Vol.163 (21), p.2639

2003

Link zum Volltext

Verfügbarkeit prüfen

P1284 Efficacy and safety of voriconazole in real-life setting in Belgium: results from the Voribel-1 trial

International journal of antimicrobial agents, 2007, Vol.29, p.S354-S354

2007

Link zum Volltext

Verfügbarkeit prüfen

A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?

International angiology, 2005-03, Vol.24 (1), p.27

2005

Link zum Volltext

Verfügbarkeit prüfen

Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation

Bone marrow transplantation (Basingstoke), 1999-05, Vol.23 (10), p.1013-1017

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(139)

Publikationsform

Artikel
(144)
Webseiten
(18)
Berichte
(8)
Reviews
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(77)
Humans
(67)
Hematology
(45)
Human Health Sciences
(40)
Sciences De La Santé Humaine
(40)
Female
(33)
Male
(30)
Laboratory Medicine & Medical Technology
(29)
Médecine De Laboratoire & Technologie Médicale
(29)
Adult
(26)
Middle Aged
(23)
Aged
(21)
Biological And Medical Sciences
(21)
Cardiovascular System & Cardiology
(20)
Peripheral Vascular Disease
(20)
Medical Sciences
(19)
General & Internal Medicine
(13)
Bleeding Time
(12)
Von Willebrand Disease
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

A comparative analysis of different automated von Willebrand factor glycoprotein Ib‐binding activity assays in well typed von Willebrand disease patients

Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole

Patient self‐management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life

B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS

P699: REAL‐LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) OR PHILADELPHIA CHROMOSOME‐POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL): 5‐YEAR‐DATA FROM A BELGIAN REGISTRY

P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B‐ALL IN ADULTS. A PHASE II HOVON TRIAL

Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions

Principles of care for the diagnosis and treatment of von Willebrand disease

Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon

Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: a randomized double‐blind clinical trial

SENSITIZATION TO THE MAMMALIAN OLIGOSACCHARIDE GALACTOSE-ALPHA-1,3- GALACTOSE (ALPHA-GAL): EXPERIENCE IN A FLEMISH CASE SERIES

Vaccination with Wilms' Tumor Antigen ( WT1) mRNA-Electroporated Dendritic Cells as an Adjuvant Treatment in 60 Cancer Patients: Report of Clinical Effects and Increased Survival in Acute Myeloid Leukemia, Metastatic Breast Cancer, Glioblastoma and Mesothelioma

Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity

The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth

The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study

A warning about agranulocytosis with the use of cocaine adulterated with levamisole

Medical and surgical management of paraneoplastic pyoderma gangrenosum--a case report and review of the literature

Therapeutic quality control of oral anticoagulant therapy comparing the short‐acting acenocoumarol and the long‐acting phenprocoumon

Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial

P1284 Efficacy and safety of voriconazole in real-life setting in Belgium: results from the Voribel-1 trial

A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?

Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation

Suchergebnisse filtern